Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

Clinical trial NCT03827343 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03827343
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Macrophage Activation Syndrome Primary Hemophagocytic Lymphohistiocytosis

Start date: 2019-01-23
Primary completion: 2026-12-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.